International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

The Genetics of Opioid Addiction Risk Evaluation Tool (GREAT) for Treatment Response in Methadone Patients

Brittany B. Dennis 1 , 2 , Monica Bawor 1 , James Paul 3 , Carolyn Plater 4 , Guillaume Pare 2 , Andrew Worster 4 , 5 , Michael Varenbut 4 , Jeff Daiter 4 , David C. Marsh 4 , 6 , Dipika Desai 7 , Lehana Thabane 2 , 8 , 9 and Zainab Samaan 2 , 7 , 10 , 11 , *
Authors Information
1 St. George’s University of London, London, United Kingdom
2 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
3 Department of Anesthesia, McMaster University, Hamilton, Canada
4 Canadian Addiction Treatment Centres, Richmond Hill, Canada
5 Department of Medicine, Hamilton General Hospital, Hamilton, Canada
6 Northern Ontario School of Medicine, Sudbury, Canada
7 Population Genomics Program, Chanchlani Research Center, McMaster University, Hamilton, Canada
8 Centre for Evaluation of Medicine, Hamilton, Canada
9 System Linked Research Unit, Hamilton, Canada
10 Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada
11 Peter Boris Centre for Addictions Research, St. Joseph’s Healthcare Hamilton, Hamilton, Canada
Article information
  • International Journal of High Risk Behaviors and Addiction: March 2017, 6 (1); e33127
  • Published Online: May 23, 2016
  • Article Type: Research Article
  • Received: September 12, 2015
  • Revised: December 28, 2015
  • Accepted: January 6, 2016
  • DOI: 10.5812/ijhrba.33127

To Cite: Dennis B B, Bawor M, Paul J, Plater C, Pare G, et al. The Genetics of Opioid Addiction Risk Evaluation Tool (GREAT) for Treatment Response in Methadone Patients, Int J High Risk Behav Addict. 2017 ; 6(1):e33127. doi: 10.5812/ijhrba.33127.

Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Hillier W. Methadone program: maintenance treatment program standards and clinical guidelines 2011;
  • 2. Organization WHO . The world health report 2002 - Reducing Risks, Promoting Healthy Life 2002;
  • 3. Bell J, Burrell T, Indig D, Gilmour S. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002. Drug Alcohol Depend. 2006; 81(1): 55-61[DOI][PubMed]
  • 4. Termorshuizen F, Krol A, Prins M, Geskus R, van den Brink W, van Ameijden EJ. Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend. 2005; 79(2): 231-40[DOI][PubMed]
  • 5. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000; 343(18): 1290-7[DOI][PubMed]
  • 6. Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004; 73(1): 23-31[PubMed]
  • 7. Ilgen MA, Trafton JA, Humphreys K. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend. 2006; 82(3): 187-93[DOI][PubMed]
  • 8. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003; 289(18): 2370-8[DOI][PubMed]
  • 9. Barry DT, Bernard MJ, Beitel M, Moore BA, Kerns RD, Schottenfeld RS. Counselors' Experiences Treating Methadone-maintained Patients with Chronic Pain: A Needs Assessment Study. J Addict Med. 2008; 2(2): 108-11[DOI][PubMed]
  • 10. Barry DT, Beitel M, Joshi D, Schottenfeld RS. Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment. Am J Addict. 2009; 18(2): 117-21[DOI][PubMed]
  • 11. van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ. 2003; 327(7410): 310[DOI][PubMed]
  • 12. Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998; 93(12): 1857-67[PubMed]
  • 13. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9(3): 199-213[PubMed]
  • 14. Leslie KM. Harm reduction: An approach to reducing risky health behaviours in adolescents. Paediatr Child Health. 2008; 13(1): 53-6
  • 15. Samaan Z, Bawor M, Dennis BB, Plater C, Varenbut M, Daiter J, et al. Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study. Neuropsychiatr Dis Treat. 2014; 10: 1503-8[DOI][PubMed]
  • 16. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59 Suppl 20: 22-33[PubMed]
  • 17. Goldstein A, Herrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend. 1995; 40(2): 139-50[PubMed]
  • 18. Hser YI, Anglin D, Powers K. A 24-year follow-up of California narcotics addicts. Arch Gen Psychiatry. 1993; 50(7): 577-84[PubMed]
  • 19. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA. 1999; 281(11): 1000-5[PubMed]
  • 20. Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry. 2007; 191: 55-62[DOI][PubMed]
  • 21. Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. J Am Med Assoc. 2000; 283(10): 1303-10
  • 22. King VL, Kidorf MS, Stoller KB, Schwartz R, Kolodner K, Brooner RK. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model. J Subst Abuse Treat. 2006; 31(4): 385-93[DOI][PubMed]
  • 23. Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009; 361(8): 777-86[DOI][PubMed]
  • 24. Streiner DL, Norman GR, Cairney J. Health measurement scales: a practical guide to their development and use. 2014;
  • 25. Means B, Nigam A, Zarrow M, Loftus EF, Donaldson MS. Autobiographical memory for health-related events. Nation Cent Health Statist Vital Health Stat. 1989; 6(2)
  • 26. Bloch R, Norman G. G String IV 2014;
  • 27. Brennan RL. Generalizability theory. 2001; [DOI]
  • 28. Stata Corp . Stata Statistical Software College Station: Release 12 2009;
  • 29. Marsden J, Nizzoli U, Corbelli C, Margaron H, Torres M, Prada De Castro I, et al. New European instruments for treatment outcome research: reliability of the maudsley addiction profile and treatment perceptions questionnaire in Italy, Spain and Portugal. Eur Addict Res. 2000; 6(3): 115-22[DOI][PubMed]
  • 30. Norman GR, Streiner DL. Biostatistics: The bare essentials 2008;
  • 31. Calcaterra S, Binswanger IA. National trends in psychostimulant-related deaths: 1999-2009. Subst Abus. 2013; 34(2): 129-36[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments